VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
Clinical trial NCT01289210 · TERMINATED
Trial details
- NCT number
- NCT01289210
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2011-11-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.